4.5 Article

Thioridazine combined with carboplatin results in synergistic inhibition of triple negative breast cancer by targeting cancer stem cells

Related references

Note: Only part of the references are listed.
Article Nanoscience & Nanotechnology

A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells

Shiyang Shen et al.

Summary: This study presents a nanoparticle-based strategy for killing CSCs in tumors by inducing CSC differentiation with all-trans retinoic acid release under hypoxic conditions and triggering cell death with camptothecin release in response to increasing reactive oxygen species levels in differentiating CSCs.

NATURE NANOTECHNOLOGY (2021)

Article Medicine, Research & Experimental

Rosmarinic acid inhibits cell proliferation, migration, and invasion and induces apoptosis in human glioma cells

Yunsheng Liu et al.

Summary: The study found that RA, as a Fyn inhibitor, has anti-tumor effects in U251 and U343 glioma cells, significantly suppressing cell proliferation, migration, and invasion, and inducing apoptosis. Additionally, RA exerts its cytotoxicity by modulating the PI3K/Akt/NF-kappa B signaling pathway.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Article Biochemistry & Molecular Biology

ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells

Dejan Vidovic et al.

CELL DEATH AND DIFFERENTIATION (2020)

Article Biochemistry & Molecular Biology

Thioridazine Enhances P62-Mediated Autophagy and Apoptosis Through Wnt/-Catenin Signaling Pathway in Glioma Cells

Cheng-Wei Chu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Pharmacology & Pharmacy

Recent therapeutic trends and promising targets in triple negative breast cancer

Soo-Yeon Hwang et al.

PHARMACOLOGY & THERAPEUTICS (2019)

Article Biochemistry & Molecular Biology

Thioridazine Sensitizes Cisplatin Against Chemoresistant Human Lung and Ovary Cancer Cells

Guanhua Qian et al.

DNA AND CELL BIOLOGY (2019)

Review Medicine, Research & Experimental

Cancer stem cell (CSC) resistance drivers

Masoud Najafi et al.

LIFE SCIENCES (2019)

Article Chemistry, Multidisciplinary

Cocktail Strategy Based on Spatio-Temporally Controlled Nano Device Improves Therapy of Breast Cancer

Tianqun Lang et al.

ADVANCED MATERIALS (2019)

Review Cell & Tissue Engineering

Cancer Stem Cells: Powerful Targets to Improve Current Anticancer Therapeutics

Rayana L. Bighetti-Trevisan et al.

STEM CELLS INTERNATIONAL (2019)

Article Oncology

Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide

Tor-Christian Johannessen et al.

INTERNATIONAL JOURNAL OF CANCER (2019)

Article Biochemistry & Molecular Biology

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

Andrew Tutt et al.

NATURE MEDICINE (2018)

Article Biochemistry & Molecular Biology

Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G1 arrest independent of DRD2

Matthew Tegowski et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

Article Oncology

Dopamine receptor D2 is correlated with gastric cancer prognosis

Jiasheng Mu et al.

ONCOLOGY LETTERS (2017)

Review Oncology

The Anticancer Activity of the Old Neuroleptic Phenothiazine-type Drug Thioridazine

Gabriella Spengler et al.

ANTICANCER RESEARCH (2016)

Article Biotechnology & Applied Microbiology

Targeting Lung Cancer Stem Cells with Antipsychological Drug Thioridazine

Haiying Yue et al.

BIOMED RESEARCH INTERNATIONAL (2016)

Review Oncology

Breast cancer stem cells: Multiple capacities in tumor metastasis

Shao-Qing Geng et al.

CANCER LETTERS (2014)

Article Biochemistry & Molecular Biology

Characterization of a Novel Transgenic Mouse Tumor Model for Targeting HER2+Cancer Stem Cells

Su He Wang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)

Review Chemistry, Medicinal

Why and How the Old Neuroleptic Thioridazine Cures the XDR-TB Patient

Leonard Amaral et al.

PHARMACEUTICALS (2012)